Chronic Thromboembolic Pulmonary Hypertension Complicated with Homocystinuria
Shinpei Ogawa(Kumamoto University), Hisao Ogawa(Kumamoto University Hospital), Hiromi Matsubara(Okayama Medical Center), Tomoko Tanaka(Kumamoto University), Eiichiro Yamamoto(Sapporo Medical University), Seiji Hokimoto(Kumamoto University), Sunao Kojima(Kumamoto University), Koichi Kaikita(Kumamoto University), Megumi Yamamuro(IRYO Sosei University), Masayo Tsukamoto(Kumamoto University), Yasuhiro Indo(Kumamoto University), Shinji Tayama(Saiseikai Kumamoto Hospital), Hiroshige Yamabe(Kumamoto University), Tetsuji Katayama(Kumamoto University), Fumio Endo(Kumamoto University), Kenichi Tsujita(Kumamoto University)
Cited by 6
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755